A Maprotiline, Ludiomil Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Maprotiline, Ludiomil Hydrochloride Certificate of Suitability (COS). The purpose of a Maprotiline, Ludiomil Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Maprotiline, Ludiomil Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Maprotiline, Ludiomil Hydrochloride to their clients by showing that a Maprotiline, Ludiomil Hydrochloride CEP has been issued for it. The manufacturer submits a Maprotiline, Ludiomil Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Maprotiline, Ludiomil Hydrochloride CEP holder for the record. Additionally, the data presented in the Maprotiline, Ludiomil Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Maprotiline, Ludiomil Hydrochloride DMF.
A Maprotiline, Ludiomil Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Maprotiline, Ludiomil Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Maprotiline, Ludiomil Hydrochloride suppliers with CEP (COS) on PharmaCompass.